Jim Hale is CEO of I-V Access Technology, Inc., which he joined in 2012. I-V Access Technology, with Venaglide TM its line of short peripheral intravenous catheters, will disrupt the current status quo for peripheral intravenous access. The Venaglide TM addresses the issues routinely encountered by practitioners and patients associated with I.V. access. I-V Access Technology is a venture capital backed medical device development company, which is out to revolutionize intravenous access devices.
Previously he was a co-founder and Managing Partner of Brown Dog Partners, a venture fund focused on commercializing technology to impact California Agriculture. Earlier, he was the Managing Director at Tramway Venture Partners. Prior to Tramway Ventures, he served as the C.O.O for Linac Systems, a compact linear accelerator manufacturer. He also worked around the new ventures space, commercializing technology out of the national laboratories and research universities along side venture capital and private equity firms, strategic partners and corporations as a Director at Technology Ventures Corporation. In 1998, he founded Avalon Airlines as his first entrepreneurial venture, which was going through FAA certification when the attacks of September 11 occurred. Before that he was a sales and marketing executive in the food industry for two Fortune 500 companies: Hormel Foods Corporation and Foodbrands/IBP. He has a BA from University of the Pacific and an MA from the University of Minnesota. He loves living in California.